High levels of HER2 expression have been reported in approximately 20% of all breast cancer tumors, resulting in a more aggressive subtype that metastasizes at a faster rate than breast tumors that do not overexpress HER2 (refs. 1,2,5–8). The gene discussed is ERBB2; the disease is breast neoplasm.